In a new experimental study, scientists from Juntendo University in collaboration with researchers from the University of Tokyo have developed an adeno-associated virus (AAV) vector-mediated ...

~ Appointment Strengthens Clinical Leadership as VectorY Prepares to Submit Investigational New Drug Application for VTx-002 in Sporadic ALS by Year-End 2025 ~ VectorY Therapeutics, a biotechnology ...